Academic Conference

Heer Medical Exhibits at the 21st National Cytopathology Annual Conference, Receiving Unanimous Recognition from Experts and Peers

2023-06-30 5 minHeer Medical Brand Center

In June 2023, the 21st National Cytopathology Conference organized by the Pathology Branch of the Chinese Medical Association and hosted by Hubei Maternal and Child Health Hospital was held in Wuhan. Heer Medical exhibited three devices, showcasing p16/Ki-67 dual staining, AI-assisted diagnosis, and other technologies, receiving unanimous recognition from experts.

The 21st National Cytopathology Conference of the Chinese Medical Association, organized by the Chinese Medical Association and the Pathology Branch of the Chinese Medical Association, and hosted by the Pathology Branch of Hubei Medical Association and Hubei Maternal and Child Health Hospital, was successfully held in Wuhan, Hubei Province from June 9 to 11, 2023.

21st National Cytopathology Conference venue

Heer Medical exhibited three devices — the "Fully Automatic Multispectral Cellular Image Analysis System," the "Multispectral Scanning Imaging System," and the "Immunohistochemical Staining Machine" — showcasing p16/Ki-67 dual staining technology and intelligent assisted diagnosis systems, cervical cell AI-assisted diagnosis systems, DNA quantitative detection technology, and more.

Heer Medical three-device exhibition booth

During the conference, numerous experts and doctors stopped at the booth to inquire and ask questions, and Heer staff patiently explained every question raised, with everyone expressing recognition and approval of Heer's products!

Experts consult and learn about products at the booth

Staff patiently explain equipment functions

p16/Ki-67 dual staining detection technology showcase

Group photo with experts during the exhibition

Experts visit Heer exhibits

21st National Cytopathology Conference successfully concludes

Many doctors and distributors inquire about Heer products

At this conference, Heer Medical newly launched the p16/Ki-67 dual staining detection kit and the cervical cell AI-assisted diagnosis system, further enriching the company's product line. Currently, the company's two product lines are advancing simultaneously:

  • Cytopathology Product Line: Comprehensively covering DNA quantification and AI cell morphology assisted diagnosis technology, providing a full-process solution for primary cervical cancer screening.
  • Immunohistochemistry Product Line: HPV E6/E7 protein and p16/Ki-67 dual staining provide a full-process intelligent solution for detecting transforming infections.

Contributing Heer's strength toward the early elimination of cervical cancer — Heer Medical looks forward to building a better future together with you!

Academic ConferenceNational Cytopathology Annual Conferencep16/Ki-67 Dual StainingAI-Assisted Diagnosis